Mannatech (MTEX) Stock Price, News & Analysis

Company Overview

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

Key Stats

• Today's Range: $9.40 to $9.56
• 50-Day Range: $8.08 to $11.97
• 52-Week Range: $6.75 to $16.49
• Volume: 1,823 shs
• Average Volume: 4,505 shs
• Market Capitalization: $17.88 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Mannatech Stock Analysis - MarketRank™

Mannatech scored higher than 29% of companies evaluated by MarketBeat, and ranked 820th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Mannatech.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Mannatech is -11.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Mannatech is -11.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Mannatech has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.55% of the float of Mannatech has been sold short.

Short Interest Ratio / Days to Cover

Mannatech has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Mannatech has recently decreased by 26.76%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Mannatech does not currently pay a dividend.

Dividend Growth

Mannatech does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.55% of the float of Mannatech has been sold short.

Short Interest Ratio / Days to Cover

Mannatech has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Mannatech has recently decreased by 26.76%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 1.44

News Sentiment

Mannatech has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Mannatech this week, compared to 0 articles on an average week.

MarketBeat Follows

1 people have added Mannatech to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Mannatech insiders have not sold or bought any company stock.

Percentage Held by Insiders

41.50% of the stock of Mannatech is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 12.98% of the stock of Mannatech is held by institutions.

MTEX Stock Analysis - Frequently Asked Questions

How have MTEX shares performed this year?

Mannatech's stock was trading at $13.43 at the start of the year. Since then, MTEX shares have decreased by 30.0% and is now trading at $9.4060.
View the best growth stocks for 2025 here.

How were Mannatech's earnings last quarter?

Mannatech, Incorporated (NASDAQ:MTEX) issued its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.80) earnings per share (EPS) for the quarter. The firm earned $26.56 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative trailing twelve-month return on equity of 15.62%.

How do I buy shares of Mannatech?

Shares of MTEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Mannatech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Mannatech investors own include CrowdStrike (CRWD), Walt Disney (DIS), Herbalife (HLF), Roku (ROKU), Alibaba Group (BABA), Enphase Energy (ENPH) and Enterprise Products Partners (EPD).

Company Calendar

• Last Earnings: 5/13/2025
• Today: 6/15/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medicinals & botanicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:MTEX
• CIK: 1056358
• Web: www.mannatech.com
• Phone: (972) 471-7400
• Fax: 972-471-8117
• Employees: 250
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.24 million
• Net Margins: -1.26%
• Pretax Margin: -0.82%
• Return on Equity: -15.62%
• Return on Assets: -3.76%

Debt

• Debt-to-Equity Ratio: 0.44
• Current Ratio: 1.25
• Quick Ratio: 0.74

Sales & Book Value

• Annual Sales: $115.04 million
• Price / Sales: 0.16
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.64 per share
• Price / Book: 1.67

Miscellaneous

• Outstanding Shares: 1,901,000
• Free Float: 1,103,000
• Market Cap: $17.88 million
• Optionable: Not Optionable
• Beta: 0.92